732 related articles for article (PubMed ID: 19103995)
21. Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease.
Dorval JF; Anderson T; Buithieu J; Chan S; Hutchison S; Huynh T; Jobin J; Lonn E; Poirier P; Title L; Walling A; Tran T; Boudreau G; Charbonneau F; Genest J
Am J Cardiol; 2005 Jan; 95(2):249-53. PubMed ID: 15642561
[TBL] [Abstract][Full Text] [Related]
22. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
Giraldez RR; Giugliano RP; Mohanavelu S; Murphy SA; McCabe CH; Cannon CP; Braunwald E
J Am Coll Cardiol; 2008 Sep; 52(11):914-20. PubMed ID: 18772061
[TBL] [Abstract][Full Text] [Related]
23. Use of atorvastatin in hyperlipidemic hypertensive renal transplant recipients.
Krmar RT; Ferraris JR; Ramirez JA; Sorroche P; Legal S; Cayssials A
Pediatr Nephrol; 2002 Jul; 17(7):540-3. PubMed ID: 12172771
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
Dogra G; Irish A; Chan D; Watts G
Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020
[TBL] [Abstract][Full Text] [Related]
25. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
Dogra GK; Watts GF; Chan DC; Stanton K
Diabet Med; 2005 Mar; 22(3):239-42. PubMed ID: 15717868
[TBL] [Abstract][Full Text] [Related]
26. Impact of the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22/Reversal of Atherosclerosis with Aggressive Lipid Lowering trials on trends in intensive versus moderate statin therapy in Ontario, Canada.
Austin PC; Mamdani MM
Circulation; 2005 Aug; 112(9):1296-300. PubMed ID: 16116054
[TBL] [Abstract][Full Text] [Related]
27. The effect of rapid lipid lowering with atorvastatin on autonomic parameters in patients with coronary artery disease.
Szramka M; Harriss L; Ninnio D; Windebank E; Brack J; Skiba M; Krum H
Int J Cardiol; 2007 Apr; 117(2):287-91. PubMed ID: 16889854
[TBL] [Abstract][Full Text] [Related]
28. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification.
Safar ME; Blacher J; Protogerou A; Achimastos A
J Hypertens; 2008 Jan; 26(1):130-7. PubMed ID: 18090550
[TBL] [Abstract][Full Text] [Related]
29. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
Dhakam Z; McEniery CM; Yasmin ; Cockcroft JR; Brown MJ; Wilkinson IB
Am J Hypertens; 2006 Feb; 19(2):214-9. PubMed ID: 16448896
[TBL] [Abstract][Full Text] [Related]
30. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
[TBL] [Abstract][Full Text] [Related]
32. Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study.
Waters DD; LaRosa JC; Barter P; Fruchart JC; Gotto AM; Carter R; Breazna A; Kastelein JJ; Grundy SM
J Am Coll Cardiol; 2006 Nov; 48(9):1793-9. PubMed ID: 17084252
[TBL] [Abstract][Full Text] [Related]
33. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
Taneva E; Borucki K; Wiens L; Makarova R; Schmidt-Lucke C; Luley C; Westphal S
Am J Cardiol; 2006 Apr; 97(7):1002-6. PubMed ID: 16563905
[TBL] [Abstract][Full Text] [Related]
34. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.
Bauersachs J; Störk S; Kung M; Waller C; Fidler F; Hoyer C; Frantz S; Weidemann F; Ertl G; Angermann CE
Eur J Clin Invest; 2007 Nov; 37(11):852-9. PubMed ID: 17973781
[TBL] [Abstract][Full Text] [Related]
35. Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysis.
Messerli FH; Pinto L; Tang SS; Thakker KM; Cappelleri JC; Sichrovsky T; Dubois RW
Am J Cardiol; 2008 Feb; 101(3):319-25. PubMed ID: 18237593
[TBL] [Abstract][Full Text] [Related]
36. Dose-related effect of statins on atrial fibrillation after cardiac surgery.
Kourliouros A; De Souza A; Roberts N; Marciniak A; Tsiouris A; Valencia O; Camm J; Jahangiri M
Ann Thorac Surg; 2008 May; 85(5):1515-20. PubMed ID: 18442529
[TBL] [Abstract][Full Text] [Related]
37. Coronary heart disease benefits from blood pressure and lipid-lowering.
Sever PS; Poulter NR; Mastorantonakis S; Chang CL; Dahlof B; Wedel H;
Int J Cardiol; 2009 Jun; 135(2):218-22. PubMed ID: 19232755
[TBL] [Abstract][Full Text] [Related]
38. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
[TBL] [Abstract][Full Text] [Related]
39. Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study.
Raison J; Rudnichi A; Safar ME
J Hum Hypertens; 2002 Oct; 16(10):705-10. PubMed ID: 12420194
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm.
Sever PS; Poulter NR; Chang CL; Thom SA; Hughes AD; Welsh P; Sattar N;
J Am Coll Cardiol; 2013 Aug; 62(8):717-29. PubMed ID: 23948514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
